| Record ID | marc_loc_updates/v37.i35.records.utf8:41388067:1696 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_updates/v37.i35.records.utf8:41388067:1696?format=raw |
LEADER: 01696cam a22003614a 4500
001 2008003218
003 DLC
005 20090831111442.0
008 080123s2008 flu a 000 0 eng
010 $a 2008003218
020 $a9781599424446 (pbk. : alk. paper)
020 $a1599424444 (pbk. : alk. paper)
035 $a(DNLM)101464424
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aKF3894.G45$bV64 2008
082 00 $a346.7304/86$222
100 1 $aVoet, Martin A.,$d1942-
245 14 $aThe generic challenge :$bunderstanding patents, FDA & pharmaceutical life-cycle management /$cMartin A. Voet.
250 $a2nd ed.
260 $aBoca Raton :$bBrownWalker Press,$c2008.
300 $axxi, 183 p. :$bill. ;$c22 cm.
505 0 $aOverview of patents -- Patent enforcement and infringement -- Pharmaceutical, biological, and medical device patents -- Overview of FDA -- Drug product exclusivity -- Hatch Waxman Act -- Putting it all together : product life-cyclemanagement.
650 0 $aDrugs$xGeneric substitution$xLaw and legislation$zUnited States.
650 0 $aDrugs$zUnited States$xGeneric substitution$xPatents.
650 0 $aPatent extensions$zUnited States.
650 0 $aPharmaceutical biotechnology$xPatents.
650 0 $aPharmaceutical biotechnology$xLaw and legislation.
650 12 $aDrugs, Generic$xeconomics$zUnited States.
650 12 $aLegislation, Drug$zUnited States.
650 22 $aDrug Industry$xeconomics$zUnited States.
650 22 $aDrug Industry$xlegislation & jurisprudence$zUnited States.
650 22 $aPatents as Topic$xlegislation & jurisprudence$zUnited States.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip089/2008003218.html